UK markets closed

G1 Therapeutics, Inc. (GTHX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.1850-0.0850 (-1.99%)
As of 02:17PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
84,041
82,511
51,301
31,476
45,285
Cost of revenue
6,815
7,195
3,748
2,016
0
Gross profit
77,226
75,316
47,553
29,460
45,285
Operating expenses
Research development
35,549
43,711
83,316
76,225
73,271
Selling general and administrative
64,506
71,132
100,415
95,692
68,490
Total operating expenses
100,055
114,843
183,731
171,917
141,761
Operating income or loss
-22,829
-39,527
-136,178
-142,457
-96,476
Interest expense
8,927
10,038
10,432
4,667
1,778
Total other income/expenses net
2,242
2,240
3
-346
-542
Income before tax
-27,476
-44,852
-145,859
-147,427
-97,844
Income tax expense
3,115
3,115
1,700
925
1,410
Income from continuing operations
-30,591
-47,967
-147,559
-148,352
-99,254
Net income
-30,591
-47,967
-147,559
-148,352
-99,254
Net income available to common shareholders
-30,591
-47,967
-147,559
-148,352
-99,254
Basic EPS
-3.38
-
-3.38
-3.54
-2.62
Diluted EPS
-3.38
-
-3.38
-3.54
-2.62
Basic average shares
43,626
-
43,626
41,943
37,878
Diluted average shares
43,626
-
43,626
41,943
37,878